The genomic and transcriptomic landscape of metastastic urothelial cancer.
Loriot Y, Kamal M, Syx L, Nicolle R, Dupain C, Menssouri N, Duquesne I, Lavaud P, Nicotra C, Ngocamus M, Lacroix L, Tselikas L, Crehange G, Friboulet L, Castel-Ajgal Z, Neuzillet Y, Borcoman E, Beuzeboc P, Marret G, Gutman T, Wong J, Radvanyi F, Dureau S, Scoazec JY, Servant N, Allory Y, Besse B, Andre F, Le Tourneau C, Massard C, Bieche I.
Nat Commun. 2024 Oct 4;15(1):8603. doi: 10.1038/s41467-024-52915-0.
PMID:39366934
Secondary Tumors of the Urinary System: An Imaging Conundrum.
Karaosmanoglu AD, Onur MR, Karcaaltincaba M, Akata D, Ozmen MN.
Korean J Radiol. 2018 Jul-Aug;19(4):742-751. doi: 10.3348/kjr.2018.19.4.742. Epub 2018 Jun 14.
PMID:29962880
The Financial Burden of Localized and Metastatic Bladder Cancer.
Scilipoti P, Moschini M, Li R, Lerner SP, Black PC, Necchi A, Rouprêt M, Shariat SF, Gupta S, Morgans AK, Psutka SP, Kamat AM.
Eur Urol. 2025 May;87(5):536-550. doi: 10.1016/j.eururo.2024.12.002. Epub 2024 Dec 26.
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer.
Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C.
J Nucl Med. 2025 May 1;66(5):732-738. doi: 10.2967/jnumed.124.269299.
PMID:40081958
A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling.
Xiong S, Li S, Li Z, Song Y, Yang L, Yang H, Xiong J, Pan W, Guo J, Fu B, Xu S.
Oncogene. 2024 Aug;43(36):2696-2707. doi: 10.1038/s41388-024-03120-2. Epub 2024 Aug 7.
PMID:39112516
Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.